BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes-Reference-Cited by-同舟云学术

BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes

Published:1994-11 Issue:3 Volume:264 Page:317-323
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Tudhope Stephen R.,Cuthbert Nigel J.,Abram Trevor S.,Jennings Michael A.,Maxey Robert J.,Thompson Angela M.,Norman Peter,Gardiner Phillip J.

Publisher

Elsevier BV

Subject

Pharmacology

Reference26 articles.

1. A new structural analogue antagonist of peptido-leukotrienes. The discovery of BAY x7195;Abram;Bioorg. Med. Chem. Letts.,1993

2. Some quantitative uses of drug antagonists;Arunlakshana;Br. J. Pharmacol. Chemother.,1959

3. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4;Buckner;J. Pharmacol. Exp. Ther.,1986

4. The role of leukotriene antagonists and inhibitors in the treatment of airway disease;Busse;Am. Rev. Resp. Dis.,1991

5. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction;Cheng;Biochem. Pharmacol.,1973

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive review;European Journal of Pharmacology;2024-09

2. MGST3 regulates BACE1 protein translation and amyloidogenesis by controlling the RGS4-mediated AKT signaling pathway;Journal of Biological Chemistry;2024-08

3. Targeted anti-inflammatory therapy is a new insight for reducing cardiovascular events: A review from physiology to the clinic;Life Sciences;2020-07

4. Uveal melanoma: progress in molecular biology and therapeutics;Therapeutic Advances in Medical Oncology;2020-01

5. Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: A systematic review of human clinical trials and in vivo animal studies;Biomedicine & Pharmacotherapy;2018-10